Claret Capital Partners has closed its fourth growth debt fund at €575M, comprising €440M of Fund IV commitments and €135M of affiliated mandates, with 32% already deployed across 27 companies.

European growth debt fund Claret Capital Partners raises €575M, with a third earmarked for biotech, medtech and diagnostics deals.

Claret’s latest fundraise exceeded its €500 million target, increasing the scale of capital available for growth lending to European companies.